Billionaire Stanley Druckenmiller's top stock pick is Arcellx (ACLX) with promising Phase 2 data

From Yahoo Finance: 2025-04-11 16:26:00

Billionaire Stanley Druckenmiller’s top 10 stock picks with huge upside potential include Arcellx, Inc. (NASDAQ:ACLX). Druckenmiller’s Duquesne Family Office consistently outperformed the S&P 500, with top 20 holdings returning 81.63% in three years. Druckenmiller’s market acumen and influence on economic policies make him a respected figure on Wall Street. His investing strategy focuses on value over hype, exiting high-profile AI stocks for undervalued opportunities. Arcellx (ACLX) is a biotech company developing immunotherapies for cancer patients, with promising Phase 2 data for relapsed or refractory multiple myeloma.

In Q4 2024, Arcellx’s financials showed a decrease in collaboration revenue, but management anticipates funding operations into 2027. The company is advancing toward a commercial launch of its lead product, anito-cel, for multiple myeloma and is developing therapies for other diseases. While ACLX ranks 5th on Druckenmiller’s list, the potential for higher returns lies in AI stocks. For investors seeking AI stocks with promising returns, a report on the cheapest AI stock may be worth considering.



Read more at Yahoo Finance: Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential